SCHEMBL25292302

SCHEMBL25292302

COc1cccc(COCCOCc2ccc(N(Cc3ccc(N4CCN(C)CC4)cc3)Cc3cccc(OC)c3)cc2)c1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ DRD2 P14416 3/20 0.44
▸ DRD4 P21917 2/20 0.44
▸ VNN1 O95497 1/20 0.43
▸ AGXT P21549 1/20 0.42
▸ USP2 O75604 1/20 0.42
▸ MAPT P10636 1/20 0.42
▸ MAPK1 P28482 1/20 0.42
▸ KMT2A Q03164 1/20 0.42
▸ ESR2 Q92731 1/20 0.42
▸ TAAR1 Q96RJ0 1/20 0.42
▸ KIT P10721 1/20 0.41
▸ HTR6 P50406 1/20 0.41
▸ ABCB1 P08183 3/20 0.41
▸ JAK2 O60674 1/20 0.41
▸ PTK2 Q05397 1/20 0.41
▸ QPCT Q16769 2/20 0.41
▸ CETP P11597 1/20 0.40
▸ CA12 O43570 1/20 0.40
▸ CA9 Q16790 1/20 0.40
▸ POLB P06746 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30245117 1.00 DRD2 (0.44) DRD2DRD4VNN1AGXTUSP2
SCHEMBL25252686 0.94 AGXT (0.50) DRD2DRD4VNN1AGXTMAPT
SCHEMBL30244840 0.94 AGXT (0.50) DRD2DRD4VNN1AGXTMAPT
SCHEMBL30245733 0.94 CETP (0.44) DRD2DRD4VNN1AGXTHTR6
SCHEMBL25291766 0.94 CETP (0.44) DRD2DRD4VNN1AGXTHTR6
SCHEMBL25251322 0.93 CNR1 (0.42) DRD2DRD4MAPTMAPK1KMT2A
SCHEMBL30245453 0.93 CNR1 (0.42) DRD2DRD4MAPTMAPK1KMT2A
SCHEMBL30245395 0.91 MAPT (0.46) DRD2DRD4AGXTMAPTMAPK1
SCHEMBL25298289 0.90 DRD2 (0.44) DRD2DRD4MAPTABCB1POLB
SCHEMBL25262893 0.90 KIT (0.43) DRD2DRD4VNN1USP2MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023018472-A9 AMINOARYL-INTEGRIN AGONISTS COMPOUNDS TEXAS HEART INSTITUTE (US) 2023-07-13 — — WO disclosed
Send feedback